Outbreak of hepatitis A in the injecting drug user and homeless populations in Bristol: Control by a targeted vaccination programme and possible parenteral transmission

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 8, 2003, Pages 901-906

  Syed, Naveed A ^a,d   Hearing, Stephen D ^b   Shaw, Ian S ^b   Probert, Christopher S J ^b   Brooklyn, Trevor N ^b   Caul, E Owen ^c   Barry, Ralph E ^b   Sarangi, Joyshri ^a  

^a Avon Health Authority   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c Department of Virology   (United Kingdom)

^d Leeds Health Protection Unit   (United Kingdom)

Author keywords

Co morbidity; Cohort; Epiderniology; Evaluation; Hepatitis A; Hepatitis C; Injecting drug users; Parenterally transmitted; Vaccination programme

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DISEASE TRANSMISSION; EPIDEMIC; FEMALE; HEALTH PROGRAM; HEPATITIS A; HEPATITIS A VIRUS; HOMELESSNESS; HUMAN; INFECTION CONTROL; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; UNITED KINGDOM; VACCINATION; VIRUS HEPATITIS; VIRUS TRANSMISSION;

EID: 0042816469     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200308000-00011     Document Type: Article

References (36)

1. Green ST, Mehsen AH, McKendrick MW, Dawes Y, Prakasam SF, Walberg R, et al. Potential for hepatitis C transmission among non-needle/syringe sharing Sheffield drug injectors through the sharing of drug preparation paraphernalia. Commun Dis Public Health 2001; 4:38-41.
2. Tennant F. Hepatitis C, B, D, and A: contrasting features and liver function abnormalities in heroin addicts. J Addict Dis 2001; 20:9-17.
3. Grinde B, Stene-Johansen K, Sharma B, Hoel T, Jensenius M, Skaug K. Characterisation of an epidemic of hepatitis A virus involving intravenous drug abusers - infection by needle sharing? J Med Virol 1997; 53:69-75.
4. Leads from the MMWR. Hepatitis A among drug abusers. JAMA 1988; 259:3235-3236, 3241.
5. Harkess J, Gildon B, Istre GR. Outbreaks of hepatitis A among illicit drug users, Oklahoma, 1984-87. Am J Public Health 1989; 79:463-466.
6. Jensenius M, Espinoza R, Hoel T, Oktedalen O, Heger B, Skar AG, et al. [An outbreak of hepatitis A among intravenous drug addicts in Oslo 1995-96.] Tidsskr Nor Laegeforen 1997; 117:935-940.
7. Jin A, Bardsley J. Intravenous drug use and hepatitis A: an investigation of an outbreak. Can J Public Health 1990; 81:79-81.
8. Leino T, Leinikki P, Hyypia T, Ristola M, Suni J, Sutinen J, et al. Hepatitis A outbreak amongst intravenous amphetamine abusers in Finland. Scand J Infect Dis 1997; 29:213-216.
9. Villano SA, Nelson KE, Vlahev D, Purcell RH, Saah AJ, Thomas DL. Hepatitis A among homosexual men and injection drug users: more evidence for vaccination. Clin Infect Dis 1997; 25:726-728.
10. Chin J. Hepatitis A. In: Chin J (editor): Control of Communicable Diseases Manual. Washington: American Public Health Association; 2000, pp. 238-243.
11. Salisbury DM, Begg NT. Hepatitis A. In: Salisbury DM, Begg NT (editors): Immunisation Against Infectious Disease. London: HMSO; 1996, pp. 85-94
12. Lemon SM. The natural history of hepatitis A: the potential for transmission by transfusion of blood or blood products. Vox Sang 1994; 67 (suppl 4):19-23.
13. Chudy M, Budek I, Keller-Stanislawski B, McCaustland KA, Neidhold S, Robertson BH, et al. A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool. J Med Virol 1999; 57:91-99.
14. Parry JV, Perry KR, Mortimer PP. Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 1987; ii:72-75.
15. Parry JV, Perry KR, Panday S, Mortimer PP. Diagnosis of hepatitis A and B by testing saliva. J Med Virol 1989; 28:255-260.
16. Marks PJ, Fey RE, Parry JV, Deakin D, Carlisle D, Neal KR. Use of hygiene advice and active immunisation to control an outbreak of hepatitis A. Commun Dis Public Health 2001; 4:158-162.
17. Santolamazza M, Delle MM, Alvino A, Bacosi M, D'Innocenzo S, Ciervo U, et al. Multiple viral infections in a group of intravenous drug users: hepatitis B virus exposure is the risk factor. Eur J Gastroenterol Hepatol 2001; 13:1347-1354.
18. Hesketh LM, Rowlatt JD, Gay NJ, Morgan-Capner P, Miller E. Childhood infection with hepatitis A and B viruses in England and Wales. Commun Dis Rep CDR Rev 1997; 7:R60-R63.
19. Iwarson S. New target groups for vaccination against hepatitis A: homosexual men, injecting drug users and patients with chronic hepatitis. Scand J Infect Dis 1998; 30:316-318.
20. Shapiro CN, Margolis HS. Worldwide epidemiology of hepatitis A virus infection. J Hepatol 1993; 18 (suppl 2):S11-S14.
21. Hepatitis A and drug misuse in the West Midlands. Commun Dis Rep CDR Wkly 1999; 9:461-464.
22. Shaw DD, Whiteman DC, Merritt AD, el-Saadi DM, Stafford RJ, Heel K, et al. Hepatitis A outbreaks among illicit drug users and their contacts in Queensland, 1997. Med J Aust 1999; 170:584-587.
23. Kern G, Frisch-Niggemeyer W, Wewalka G, Bruns C. [Hepatitis A outbreak in a shelter for the homeless in Vienna.] Wien Klin Wochenschr 1986; 98:457-461.
24. Merritt A, Symons D, Griffiths M. The epidemiology of acute hepatitis A in north Queensland, 1996-1997. Commun Dis Intell 1999; 23:120-124.
25. Scheutz F, Skinhoj P, Mark I. Viral hepatitis among parenteral drug addicts attending a Danish addiction clinic. Scand J Infect Dis 1983; 15:139-143.
26. O'Donovan D, Cooke RP, Joce R, Eastbury A, Waite J, Stene-Johansen K. An outbreak of hepatitis A amongst injecting drug users. Epidemiol Infect 2001; 127:469-473.
27. Thorburn KM, Bohorques R, Stepak P, Smith LL, Jobb C, Smith JP. Immunization strategies to control a community-wide hepatitis A epidemic. Epidemiol Infect 2001; 127:461-467.
28. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995; 90:201-205.
29. Lefilliatre P, Villeneuve JP. Fulminant hepatitis A in patients with chronic liver disease. Can J Public Health 2000; 91:168-170.
30. Manns MP, Schuler A. Risk of hepatitis A superinfection in patients with underlying liver disease. Acta Gastroenterol Belg 1998; 61:206-209.
31. O'Grady JG. Fulminant hepatitis in patients with chronic liver disease. J Viral Hepat 2000; 7 (suppl 1):9-10.
32. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338:286-290.
33. Crofts N, Cooper G, Stewart T, Kiely P, Coghlan P, Hearne P, et al. Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria. J Viral Hepat 1997; 4:333-338.
34. Hutin YJ, Sabin KM, Hutwagner LC, Schaben L, Shipp GM, Lord DM, et al. Multiple modes of hepatitis A virus transmission among methamphetamine users. Am J Epidemiol 2000; 152:186-192.
35. Crowcroft NS, Walsh B, Davison KL, Gungabissoon U. Guidelines for the control of hepatitis A virus infection. Commun Dis Public Health 2001; 4:213-227.
36. Anis E, Leventhal A, Roitman M, Slater PE. [Introduction of routine hepatitis A immunization in Israel - the first in the world.] Harefuah 2000; 138:177-180.